Geneva, Geneva, Switzerland
I’m a senior executive in global health and innovation with nearly two decades of leadership experience driving strategic growth, partnerships, and organisational transformation — contributing to health interventions estimated to have saved over 17 million lives. As Vice President and Head of Resource Mobilisation at MMV, I lead the strategy and systems that power our global funding engine. My role spans strategic foresight, cross-sector collaboration, and enterprise-level influence — aligning institutional ambition with external opportunity, even in the most complex and rapidly evolving landscapes. Earlier in my career, I held leadership roles at UNICEF and the World Heart Federation, where I shaped global platforms, led transformative income strategies, and championed systemic change. I bring to the global health space over 20 years of commercial leadership, including at The Coca-Cola Company, where I managed product innovation, brand execution, and operational scale across 67 markets. I operate where vision meets delivery — shaping strategy, building high-performing teams, and translating mission into measurable, sustainable outcomes. What I bring to the C-suite: • Cross-sector leadership at scale — non-profit, public, and commercial • Strategy, innovation, and operational rigour in equal measure • Experience influencing global agendas and navigating complex geopolitics • Proven ability to design systems for financial resilience and transparency • Inclusive, high-trust leadership with a people-first mindset • Skilled communicator and bridge-builder across science, policy, and business • Track record of driving growth, transformation, and mission-driven results If your work sits at the intersection of equity, science, and impact — or you're building the next wave of purpose-led leadership — I’d welcome the conversation.
MMV, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV's vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease. Strategic Thought Leadership: Consistently provided strategic guidance to senior leadership, playing a key role in shaping MMV's new 2030 strategy, and ensuring robust engagement, risk management, and mitigation. Pandemic Preparedness: Conceptualized and initiated a pandemic therapeutic drug discovery platform, securing prospects for $100 million USD for its 5-year operational period. Fundraising Excellence: Successfully led all fundraising activities at MMV engaging governments, foundations and trusts at the highest level, securing critical support, including $180 million USD from the Gates Foundation and $15 million USD from the UK Government for a COVID-19 therapeutic trial. Innovative Financial Management: Pioneered the CAT (Cost Allocation Tool), a revolutionary financial management system sought after by industry leaders, enhancing transparency and data driven decision-making.
Income Generation: Successfully launched the "25x25" platform, substantially boosting income and forging strategic partnerships with prominent pharmaceutical companies. Champion Advocates: Established the Champion Advocates Programme to reduce premature mortality from cardiovascular disease by 25% by 2025, recruiting and mobilizing experts.
Transformational Change: Led a comprehensive transformation of UNICEF's Sales and Marketing business, optimizing efficiency and reducing workforce size while maintaining profitability. Centralized Marketing: Centralized marketing materials development, significantly reducing campaign development time to a matter of weeks. Under his leadership and vision, UNICEF has generated over $400 million of regular resource net income in the last 8 years from sales of UNICEF goods in 67 markets. Innovation in business and operating models have been developed and implemented with lasting impacts to the organization.
Operational Centralization: Spearheaded the centralization of design services for 69 countries and over 160 brands, optimizing responsiveness and cost-effectiveness, and positioning the hub as the global benchmark for new product management. As a result of his leadership and business development skills, the unit provided a full creative service to 67 markets (including part of the US) and over 167 Brands and sub-brands, all with an enviable time to market (60 day fast track). Realized significant savings in cost to market, greater brand integrity, improved business responsiveness, and creative excellence e.g. reduced marketing design expenses by 50% in 3 years (reduced by $2 million in 2001 alone).
Developed one of the company's most successful brands - Avon Naturals (still in the Avon's product portfolio). Conducted a global rationalization of the Personal Care offer (first of its kind), so creating truly Global Brands, capable of leveraging economies of scales and brand management possibilities. Led the product development work stream associated with the closure of one of three European manufacturing sites and the redistribution to the remaining two sites. Led the development of the Brand look with all associated packaging, designs, logotypes etc. for any new brand extensions or introductions including claims based formula related developments e.g. anti aging etc. Concept to final manufacturing. Full technical and financial analysis of any new brand launches in support of a defined marketing plan.